Analyst Thinks Johnson & Johnson Could Hit a $280 Target
A major analyst raises the price target on Johnson & Johnson to $280, arguing growing oncology sales and a planned sp...
Learn how to identify crypto coins to hold long term based on fundamentals, use cases, and risk tolerance. Build a resilient, diversified portfolio with smart criteria.
28,040 articlesA major analyst raises the price target on Johnson & Johnson to $280, arguing growing oncology sales and a planned sp...
A veteran analyst warns that today may be one of the most dangerous eras for passive investing. With stocks near all-...
As SoFi expands beyond student loan refi, the question for investors is clear: where will SoFi Technologies be in fiv...
A wave of headlines around massive news PayPal stock has investors scanning the market for clues. This article breaks...
Active traders face a shifting landscape as FINRA revamps margin rules. This guide breaks down understanding intraday...
Warren Buffett's successor, Greg Abel, is drawing new attention as recent 13F filings hint at a shift in Berkshire's ...
Doximity sits at a crossroads: a robust physician network with multiple monetization channels, yet facing disruption ...
What if a philanthropic powerhouse holds a large share of its stock in just a few mega-cap names? This article explor...
A 70-year-old aims to generate $69,600 a year from a $1.1 million portfolio, testing whether higher-yield income stra...
Tech stocks retreat sparked a broader market pause, but analysts insist the stock market isn’t crashing — it’s a rota...
A high-yield dividend stock can be attractive, but sustainability matters. This article breaks down how this 12.5%-yi...
As July 1 approaches, caps on federal student loan borrowing under the One Big Beautiful Bill Act threaten graduate a...